Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Dare Bioscience Inc (DARE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Dare Bioscience's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.3059 +0.0167    +5.77%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.3059
-0.0000
-0.0000%
23:36:03 - Real-time Data
  • Volume: 170,353
  • Bid/Ask: 0.2950 / 0.3059
  • Day's Range: 0.2880 - 0.3084
Type:  Equity
Market:  United States
Dare Bioscience 0.3059 +0.0167 +5.77%

Dare Bioscience Company Profile

 
Read the Dare Bioscience Inc company profile to learn more about the business and the management team. View Dare Bioscience Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

25

Equity Type

ORD

Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women’s health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California.

Contact Information

Address 3655 Nobel Drive Suite 260
San Diego, 92122
United States
Phone 858 926 7655
Fax -

Top Executives

Name Age Since Title
Susan L. Kelley 68 2014 Independent Director
Robin J. Steele 67 2017 Independent Director
Jessica D. Grossman 51 2018 Independent Director
Gregory W. Matz 63 2018 Independent Director
William H. Rastetter 75 2014 Independent Chairman of the Board
Robert S. Langer 74 2019 Member of Scientific Advisory Board
Sabrina Martucci Johnson 57 2015 CEO, President, Principal Financial Officer, Secretary & Director
Cheryl Renee Blanchard 60 2019 Independent Director
Sophia N. Ononye-Onyia 39 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DARE Price Commentary

Write your thoughts about Dare Bioscience Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dipak Kerai
Dipak Kerai Mar 16, 2021 19:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like this stock and buying on the dips averaging down... i see long term upside which looks better than downside once they start rolling out thwir products some day...
HMKing Constantine
HMKing Constantine Mar 16, 2021 19:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it worth to entry now?
Liew ST
Liew ST Mar 04, 2021 16:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2021.03.04 @$2. Smarter Analyst Tgt $9. Consensus $7.17
Romain Clouet
Romain Clouet Aug 28, 2020 12:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should i bare dare asnit remains at 1 dollar ?
HGD Group
HGD Group May 16, 2018 16:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DARE is one of the most interesting pharm. companies for last few years.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email